{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:29:40Z","timestamp":1790371780342,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["17-00-00171, 17-54-12007, 18-29-09090, 18-515-4501"],"award-info":[{"award-number":["17-00-00171, 17-54-12007, 18-29-09090, 18-515-4501"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1136\/ijgc-2018-000175","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T07:16:19Z","timestamp":1551856579000},"page":"779-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["BRCA1-associated and sporadic ovarian carcinomas: outcomes of primary cytoreductive surgery or neoadjuvant chemotherapy"],"prefix":"10.1016","volume":"29","author":[{"given":"Tatyana","family":"Gorodnova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sokolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr","family":"Ivantsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khristina","family":"Kotiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Petrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Amelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Berlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Imyanitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2018-000175_bb0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"The Lancet"},{"key":"10.1136\/ijgc-2018-000175_bb0015","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation\u2013Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"JCO"},{"key":"10.1136\/ijgc-2018-000175_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.canlet.2015.08.028","article-title":"High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation","volume":"369","author":"Gorodnova","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1136\/ijgc-2018-000175_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1136\/ijgc-2018-000175_bb0030","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2009.25.1082","article-title":"Increased incidence of visceral metastases in Scottish patients with BRCA1\/2-defective ovarian cancer: an extension of the ovarian BRCAness phenotype","volume":"28","author":"Gourley","year":"2010","journal-title":"JCO"},{"key":"10.1136\/ijgc-2018-000175_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13053-016-0057-2","article-title":"Cytotoxic and targeted therapy for hereditary cancers","volume":"14","author":"Iyevleva","year":"2016","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1136\/ijgc-2018-000175_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/1078-0432.CCR-14-2497","article-title":"Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer","volume":"21","author":"Candido-dos-Reis","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2018-000175_bb0045","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-018-3532-9","article-title":"PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer","volume":"81","author":"Morgan","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1136\/ijgc-2018-000175_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1897-4287-7-5","article-title":"High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients","volume":"7","author":"Suspitsin","year":"2009","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1136\/ijgc-2018-000175_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10689-007-9120-5","article-title":"Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia","volume":"6","author":"Sokolenko","year":"2007","journal-title":"Fam Cancer"},{"key":"10.1136\/ijgc-2018-000175_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cancergencyto.2009.10.003","article-title":"High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases","volume":"197","author":"Moiseyenko","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1136\/ijgc-2018-000175_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2018-000175_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/EDBK_160624","article-title":"Primary surgery or neoadjuvant chemotherapy in advanced ovarian cancer: the debate continues\u2026","volume":"36","author":"Leary","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1136\/ijgc-2018-000175_bb0075","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.ajog.2017.05.036","article-title":"BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study","volume":"217","author":"Petrillo","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000175_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2017.03.036","article-title":"Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers","volume":"397","author":"Sokolenko","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1136\/ijgc-2018-000175_bb0085","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1245\/s10434-018-6700-6","article-title":"BRCA mutation status to personalize management of recurrent ovarian cancer: a multicenter study","volume":"25","author":"Marchetti","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2018-000175_bb0090","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1086\/302922","article-title":"Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer","volume":"66","author":"G\u00f3rski","year":"2000","journal-title":"Am J Hum Genet"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24011423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24011423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2018-000175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:21Z","timestamp":1753223901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24011423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1048891X24011423"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2018-000175","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCA1-associated and sporadic ovarian carcinomas: outcomes of primary cytoreductive surgery or neoadjuvant chemotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2018-000175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}